Search

Author/Creator Rossi, John M

1. Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial. Issue 1 (January 2022)

Authors:
Jacobson, Caron A; Chavez, Julio C; Sehgal, Alison R; William, Basem M; Munoz, Javier; Salles, Gilles; Munshi, Pashna N; Casulo, Carla; Maloney, David G; de Vos, Sven; Reshef, Ran; Leslie, Lori A; Yakoub-Agha, Ibrahim; Oluwole, Olalekan O; Fung, Henry Chi Hang; Rosenblatt, Joseph; Rossi, John M; ...
Journal:
Lancet oncology
Issue:
Volume 23:Issue 1(2022)
Page Start:
91
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study. Issue 10299 (7th August 2021)

Authors:
Shah, Bijal D; Ghobadi, Armin; Oluwole, Olalekan O; Logan, Aaron C; Boissel, Nicolas; Cassaday, Ryan D; Leguay, Thibaut; Bishop, Michael R; Topp, Max S; Tzachanis, Dimitrios; O'Dwyer, Kristen M; Arellano, Martha L; Lin, Yi; Baer, Maria R; Schiller, Gary J; Park, Jae H; Subklewe, Marion; Abedi, Me...
Journal:
Lancet
Issue:
Volume 398:Issue 10299(2021)
Page Start:
491
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial. Issue 1 (January 2019)

Authors:
Locke, Frederick L; Ghobadi, Armin; Jacobson, Caron A; Miklos, David B; Lekakis, Lazaros J; Oluwole, Olalekan O; Lin, Yi; Braunschweig, Ira; Hill, Brian T; Timmerman, John M; Deol, Abhinav; Reagan, Patrick M; Stiff, Patrick; Flinn, Ian W; Farooq, Umar; Goy, Andre; McSweeney, Peter A; Munoz, Javie...
Journal:
Lancet oncology
Issue:
Volume 20:Issue 1(2019)
Page Start:
31
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Management of a patient with mantle cell lymphoma who developed severe neurotoxicity after chimeric antigen receptor T-cell therapy in ZUMA-2. Issue 2 (16th October 2020)

Authors:
Wang, Michael; Jain, Preetesh; Chi, T Linda; Chen, Sheree E; Heimberger, Amy; Weathers, Shiao-Pei; Zheng, Lianqing; Rao, Arati V; Rossi, John M
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Management of a patient with mantle cell lymphoma who developed severe neurotoxicity after chimeric antigen receptor T-cell therapy in ZUMA-2. Issue 2 (16th October 2020)

Authors:
Wang, Michael; Jain, Preetesh; Chi, T Linda; Chen, Sheree E; Heimberger, Amy; Weathers, Shiao-Pei; Zheng, Lianqing; Rao, Arati V; Rossi, John M
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Management of a patient with mantle cell lymphoma who developed severe neurotoxicity after chimeric antigen receptor T-cell therapy in ZUMA-2. Issue 2 (16th October 2020)

Authors:
Wang, Michael; Jain, Preetesh; Chi, T Linda; Chen, Sheree E; Heimberger, Amy; Weathers, Shiao-Pei; Zheng, Lianqing; Rao, Arati V; Rossi, John M
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Management of a patient with mantle cell lymphoma who developed severe neurotoxicity after chimeric antigen receptor T-cell therapy in ZUMA-2. Issue 2 (16th October 2020)

Authors:
Wang, Michael; Jain, Preetesh; Chi, T Linda; Chen, Sheree E; Heimberger, Amy; Weathers, Shiao-Pei; Zheng, Lianqing; Rao, Arati V; Rossi, John M
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Management of a patient with mantle cell lymphoma who developed severe neurotoxicity after chimeric antigen receptor T-cell therapy in ZUMA-2. Issue 2 (16th October 2020)

Authors:
Wang, Michael; Jain, Preetesh; Chi, T Linda; Chen, Sheree E; Heimberger, Amy; Weathers, Shiao-Pei; Zheng, Lianqing; Rao, Arati V; Rossi, John M
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Management of a patient with mantle cell lymphoma who developed severe neurotoxicity after chimeric antigen receptor T-cell therapy in ZUMA-2. Issue 2 (16th October 2020)

Authors:
Wang, Michael; Jain, Preetesh; Chi, T Linda; Chen, Sheree E; Heimberger, Amy; Weathers, Shiao-Pei; Zheng, Lianqing; Rao, Arati V; Rossi, John M
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Management of a patient with mantle cell lymphoma who developed severe neurotoxicity after chimeric antigen receptor T-cell therapy in ZUMA-2. Issue 2 (16th October 2020)

Authors:
Wang, Michael; Jain, Preetesh; Chi, T Linda; Chen, Sheree E; Heimberger, Amy; Weathers, Shiao-Pei; Zheng, Lianqing; Rao, Arati V; Rossi, John M
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗